ALYSSA LEWIS: Open Payments
NPI 1841950581 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 24 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,107 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| Biosense Webster, Inc. | 2 | $256 |
| Medtronic, Inc. | 2 | $171 |
| Amgen Inc. | 1 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90 |
| Alnylam Pharmaceuticals Inc. | 3 | $81 |
| PFIZER INC. | 3 | $64 |
| BridgeBio Pharma, Inc. | 2 | $60 |
| Boston Scientific Corporation | 2 | $50 |
| Abbott Laboratories | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
Products named: AFFERA MAPPING SYSTEM, CARTO 3, QDOT MICRO, REPATHA, JARDIANCE, AMVUTTRA, VYNDAQEL, Attruby.
Industry payments across CA — which companies pay providers there.
